Key Financial Data Of Reporting Company

ASKA Pharmaceutical Holdings CO., Ltd. - Filing #7557806

Concept As at
2023-03-31
As at
2023-03-31
As at
2023-03-31
As at
2023-03-31
As at
2023-03-31
2022-04-01 to
2023-03-31
As at
2023-03-31
As at
2023-03-31
2022-04-01 to
2023-03-31
2021-04-01 to
2022-03-31
As at
2022-03-31
2021-04-01 to
2022-03-31
As at
2022-03-31
Key financial data of reporting company
Business results of reporting company
Net sales
60,461,000,000 JPY
56,607,000,000 JPY
Operating revenue
1,732,000,000 JPY
1,371,000,000 JPY
Ordinary profit (loss)
603,000,000 JPY
5,232,000,000 JPY
717,000,000 JPY
4,880,000,000 JPY
Profit (loss)
591,000,000 JPY
682,000,000 JPY
Share capital
1,197,000,000 JPY
1,197,000,000 JPY
Total number of issued shares
30,563,199 xbrli:shares
30,563,199 xbrli:shares
Net assets
54,533,000,000 JPY
40,944,000,000 JPY
40,695,000,000 JPY
48,892,000,000 JPY
Total assets
87,138,000,000 JPY
41,575,000,000 JPY
41,301,000,000 JPY
83,297,000,000 JPY
Net assets per share
1,928.14
1,447.55
1,443.94
1,734.80
Dividend paid per share
16.00
15.00
Interim dividend paid per share
8.00
7.00
Basic earnings (loss) per share
20.95
150.08
23.79
151.22
Diluted earnings per share
Equity-to-asset ratio
0.6258 xbrli:pure
0.985 xbrli:pure
0.985 xbrli:pure
0.5870 xbrli:pure
Rate of return on equity
0.0145 xbrli:pure
0.0820 xbrli:pure
0.0168 xbrli:pure
0.0877 xbrli:pure
Price-earnings ratio
56.76 xbrli:pure
7.92 xbrli:pure
53.10 xbrli:pure
8.35 xbrli:pure
Payout ratio
0.764 xbrli:pure
0.336 xbrli:pure
Net cash provided by (used in) operating activities
3,351,000,000 JPY
2,842,000,000 JPY
Net cash provided by (used in) investing activities
-1,126,000,000 JPY
6,743,000,000 JPY
Net cash provided by (used in) financing activities
-1,820,000,000 JPY
-2,996,000,000 JPY
Cash and cash equivalents
17,505,000,000 JPY
17,103,000,000 JPY
Number of employees
36 xbrli:pure
87 xbrli:pure
747 xbrli:pure
79 xbrli:pure
610 xbrli:pure
14 xbrli:pure
79 xbrli:pure
74 xbrli:pure
777 xbrli:pure
Average number of temporary employees
6 xbrli:pure
16 xbrli:pure
117 xbrli:pure
92 xbrli:pure
3 xbrli:pure
101 xbrli:pure
Total shareholder return
0.954 xbrli:pure
xbrli:pure
Total return on share price index
1.148 xbrli:pure
xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.